Copyright Reports & Markets. All rights reserved.

Global Transdermal Drug Delivery Systems Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Fentanyl
    • 1.4.3 Nitroglycerin
    • 1.4.4 Estradiol
    • 1.4.5 Nicotine
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global Transdermal Drug Delivery Systems Market Share by Application: 2020 VS 2026
    • 1.5.2 OTC
    • 1.5.3 Rx
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Transdermal Drug Delivery Systems Market Perspective (2015-2026)
  • 2.2 Global Transdermal Drug Delivery Systems Growth Trends by Regions
    • 2.2.1 Transdermal Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Transdermal Drug Delivery Systems Historic Market Share by Regions (2015-2020)
    • 2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Transdermal Drug Delivery Systems Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Transdermal Drug Delivery Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Transdermal Drug Delivery Systems Players by Market Size
    • 3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2015-2020)
    • 3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Transdermal Drug Delivery Systems Market Concentration Ratio
    • 3.2.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2019
  • 3.3 Transdermal Drug Delivery Systems Key Players Head office and Area Served
  • 3.4 Key Players Transdermal Drug Delivery Systems Product Solution and Service
  • 3.5 Date of Enter into Transdermal Drug Delivery Systems Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2015-2020)
  • 4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
  • 5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Transdermal Drug Delivery Systems Market Size (2015-2020)
  • 6.2 Transdermal Drug Delivery Systems Key Players in North America (2019-2020)
  • 6.3 North America Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
  • 6.4 North America Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Transdermal Drug Delivery Systems Market Size (2015-2020)
  • 7.2 Transdermal Drug Delivery Systems Key Players in Europe (2019-2020)
  • 7.3 Europe Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
  • 7.4 Europe Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

8 China

  • 8.1 China Transdermal Drug Delivery Systems Market Size (2015-2020)
  • 8.2 Transdermal Drug Delivery Systems Key Players in China (2019-2020)
  • 8.3 China Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
  • 8.4 China Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Transdermal Drug Delivery Systems Market Size (2015-2020)
  • 9.2 Transdermal Drug Delivery Systems Key Players in Japan (2019-2020)
  • 9.3 Japan Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
  • 9.4 Japan Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Transdermal Drug Delivery Systems Market Size (2015-2020)
  • 10.2 Transdermal Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

11 India

  • 11.1 India Transdermal Drug Delivery Systems Market Size (2015-2020)
  • 11.2 Transdermal Drug Delivery Systems Key Players in India (2019-2020)
  • 11.3 India Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
  • 11.4 India Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Transdermal Drug Delivery Systems Market Size (2015-2020)
  • 12.2 Transdermal Drug Delivery Systems Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
  • 12.4 Central & South America Transdermal Drug Delivery Systems Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Hisamitsu
    • 13.1.1 Hisamitsu Company Details
    • 13.1.2 Hisamitsu Business Overview
    • 13.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
    • 13.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2015-2020))
    • 13.1.5 Hisamitsu Recent Development
  • 13.2 Mylan
    • 13.2.1 Mylan Company Details
    • 13.2.2 Mylan Business Overview
    • 13.2.3 Mylan Transdermal Drug Delivery Systems Introduction
    • 13.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.2.5 Mylan Recent Development
  • 13.3 GSK
    • 13.3.1 GSK Company Details
    • 13.3.2 GSK Business Overview
    • 13.3.3 GSK Transdermal Drug Delivery Systems Introduction
    • 13.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.3.5 GSK Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview
    • 13.4.3 Novartis Transdermal Drug Delivery Systems Introduction
    • 13.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 Teve(Actavis)
    • 13.5.1 Teve(Actavis) Company Details
    • 13.5.2 Teve(Actavis) Business Overview
    • 13.5.3 Teve(Actavis) Transdermal Drug Delivery Systems Introduction
    • 13.5.4 Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.5.5 Teve(Actavis) Recent Development
  • 13.6 Johnson & Johnson
    • 13.6.1 Johnson & Johnson Company Details
    • 13.6.2 Johnson & Johnson Business Overview
    • 13.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
    • 13.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.6.5 Johnson & Johnson Recent Development
  • 13.7 UCB
    • 13.7.1 UCB Company Details
    • 13.7.2 UCB Business Overview
    • 13.7.3 UCB Transdermal Drug Delivery Systems Introduction
    • 13.7.4 UCB Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.7.5 UCB Recent Development
  • 13.8 Teikoku Seiyaku
    • 13.8.1 Teikoku Seiyaku Company Details
    • 13.8.2 Teikoku Seiyaku Business Overview
    • 13.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
    • 13.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.8.5 Teikoku Seiyaku Recent Development
  • 13.9 Bayer
    • 13.9.1 Bayer Company Details
    • 13.9.2 Bayer Business Overview
    • 13.9.3 Bayer Transdermal Drug Delivery Systems Introduction
    • 13.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.9.5 Bayer Recent Development
  • 13.10 Lingrui
    • 13.10.1 Lingrui Company Details
    • 13.10.2 Lingrui Business Overview
    • 13.10.3 Lingrui Transdermal Drug Delivery Systems Introduction
    • 13.10.4 Lingrui Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 13.10.5 Lingrui Recent Development
  • 13.11 Sanofi
    • 10.11.1 Sanofi Company Details
    • 10.11.2 Sanofi Business Overview
    • 10.11.3 Sanofi Transdermal Drug Delivery Systems Introduction
    • 10.11.4 Sanofi Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 10.11.5 Sanofi Recent Development
  • 13.12 Qizheng
    • 10.12.1 Qizheng Company Details
    • 10.12.2 Qizheng Business Overview
    • 10.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
    • 10.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 10.12.5 Qizheng Recent Development
  • 13.13 Endo
    • 10.13.1 Endo Company Details
    • 10.13.2 Endo Business Overview
    • 10.13.3 Endo Transdermal Drug Delivery Systems Introduction
    • 10.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 10.13.5 Endo Recent Development
  • 13.14 Huarun 999
    • 10.14.1 Huarun 999 Company Details
    • 10.14.2 Huarun 999 Business Overview
    • 10.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
    • 10.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 10.14.5 Huarun 999 Recent Development
  • 13.15 Haw Par
    • 10.15.1 Haw Par Company Details
    • 10.15.2 Haw Par Business Overview
    • 10.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
    • 10.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 10.15.5 Haw Par Recent Development
  • 13.16 Nichiban
    • 10.16.1 Nichiban Company Details
    • 10.16.2 Nichiban Business Overview
    • 10.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
    • 10.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 10.16.5 Nichiban Recent Development
  • 13.17 Mentholatum Company
    • 10.17.1 Mentholatum Company Company Details
    • 10.17.2 Mentholatum Company Business Overview
    • 10.17.3 Mentholatum Company Transdermal Drug Delivery Systems Introduction
    • 10.17.4 Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 10.17.5 Mentholatum Company Recent Development
  • 13.18 Laboratoires Genevrier
    • 10.18.1 Laboratoires Genevrier Company Details
    • 10.18.2 Laboratoires Genevrier Business Overview
    • 10.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
    • 10.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
    • 10.18.5 Laboratoires Genevrier Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Transdermal Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Hisamitsu
    Mylan
    GSK
    Novartis
    Teve(Actavis)
    Johnson & Johnson
    UCB
    Teikoku Seiyaku
    Bayer
    Lingrui
    Sanofi
    Qizheng
    Endo
    Huarun 999
    Haw Par
    Nichiban
    Mentholatum Company
    Laboratoires Genevrier

    Market segment by Type, the product can be split into
    Fentanyl
    Nitroglycerin
    Estradiol
    Nicotine
    Other
    Market segment by Application, split into
    OTC
    Rx

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now